Fundz

Fundz Deep Dive

Everything you need to win Amsel Medical Corporation — in one platform.

Who to reach, what to say, and why now on Amsel Medical Corporation — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Amsel Medical Corporation — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Amsel Medical Signs $7.45M Phase III SBIR Contract for SCureTO™ Precision Hemorrhage Control Solution

Oct 02, 2024•over 1 year ago

Contract Type

contract

CambridgeManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Amsel Medical Corporation has been awarded a $7.45 million sole source, non-dilutive, small business innovative research (SBIR) Phase III contract by the United States Air Force to accelerate the commercialization of their breakthrough SCureTO™ precision hemorrhage control solution for combat casualty care trauma.

Company Information

Company

Amsel Medical Corporation

Location

Cambridge, Massachusetts, United States

About

Amsel Medical Corporation is a medical device company, based in Cambridge, Massachusetts, delivering simple and secure technology for vessel and tubular structure occlusion. In addition to its temporary trauma solution, it is also commercializing a permanent implant (SCureClamp™).

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Amsel Medical Corporation's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.